Fentanyl could be the next wave of the drugs crisis and Government drugs policy is ill-prepared for it, an expert on drug treatment has warned.
Passerose Mantoy, chief executive of the Chrysalis community drug project in Dublin’s north inner city, said strategies to combat drug abuse and to support people in addiction needed to be “more proactive and less reactive”.
“The drug industry moves fast and they are ingenious in promoting and getting their product to market, so we need to get ahead. What will be the next drug hitting the Irish market? Will we be prepared?”
She said several years ago no one believed crack cocaine would be widely used here. “Now I would say all our service users are using crack.
Markets in Vienna or Christmas at The Shelbourne? 10 holiday escapes over the festive season
Ciara Mageean: ‘I just felt numb. It wasn’t even sadness, it was just emptiness’
Stealth sackings: why do employers fire staff for minor misdemeanours?
Carl and Gerty Cori: a Nobel Prizewinning husband and wife team
“Illicit fentanyl is causing havoc on the streets of America, with 100,000 deaths because of it in 2021.” Fentanyl is a synthetic opiate, used to treat pain when prescribed but increasingly being manufactured illicitly in the United States where it is behind an escalating number of drug overdose fatalities.
Ms Mantoy was speaking on Thursday at the publication of Chrysalis’s strategic plan 2023-2025. The charity has provided supports and services to drug users and their families in the Dublin 7 area since 1998 and more recently in Dublin 1.
She said all drugs services were “trying our best to address the drug crisis and support individuals in addiction but we need a more concerted effort from the State to fund and support addiction and mental health services.
“Since Covid we have seen many experienced workers leaving the field or experiencing burnout. To respond adequately we need to retain our staff by supporting them, acknowledging and valuing their work and remunerating them appropriately.”
Also on Thursday, Merchants Quay Ireland (MQI) reported an almost one fifth increase in demand for its services last year. Its 2021 annual review showed an increase of more than a quarter (27 per cent) in demand for its harm-reduction services — to 49,448.
“In 2021, despite the continuing impact of Covid-19, MQI saw an overall increase of 17 per cent in clients across the organisation. This was a total of 11,621 unique individuals,” said its chief executive Paula Byrne.
“Last year 4,095 of our clients were registered as homeless [and] specifically, in Q4 of 2021, the number of clients presenting as newly homeless increased by 55 per cent compared to [the same period] the previous year. This increase is due to the lifting of eviction bans, the reality of Covid-19 job losses, and increasing rent prices in 2021.”
She said the majority of those who engaged with the charity’s mental health team last year had a dual diagnosis of both mental health and substance use issues.
“Without access to specialist services, clients with a dual diagnosis often struggle to have their serious health and social care needs met.
“We welcome the allocation of resources and funding to the clinical care programme for dual diagnosis, and hope this programme will lead to greater collaboration and inter-agency responses,” said Ms Byrne.
